nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Hydroxyurea—psoriasis	0.0816	0.441	CbGbCtD
Hydroxychloroquine—CYP2D6—Cholecalciferol—psoriasis	0.0494	0.267	CbGbCtD
Hydroxychloroquine—CYP2D6—Cyclosporine—psoriasis	0.0325	0.176	CbGbCtD
Hydroxychloroquine—CYP2D6—Dexamethasone—psoriasis	0.0214	0.116	CbGbCtD
Hydroxychloroquine—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.0076	0.0359	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00709	0.0335	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.00471	0.0223	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL12B—psoriasis	0.00418	0.0197	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—TNF—psoriasis	0.00381	1	CrCbGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNFAIP3—psoriasis	0.00379	0.0179	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL12B—psoriasis	0.0033	0.0156	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL12B—psoriasis	0.00326	0.0154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNFAIP3—psoriasis	0.00299	0.0141	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—psoriasis	0.00268	0.0127	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—SOCS1—psoriasis	0.00266	0.0126	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—NFKBIA—psoriasis	0.00263	0.0125	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—SOCS1—psoriasis	0.00263	0.0124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL12B—psoriasis	0.00258	0.0122	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—psoriasis	0.00254	0.012	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KIR2DS1—psoriasis	0.00243	0.0115	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—NFKBIA—psoriasis	0.00234	0.0111	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—psoriasis	0.0022	0.0104	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—TYK2—psoriasis	0.00216	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—psoriasis	0.00212	0.01	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—SOCS1—psoriasis	0.0021	0.00993	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NFKBIA—psoriasis	0.00208	0.00984	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TYK2—psoriasis	0.00208	0.00984	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—SOCS1—psoriasis	0.00208	0.00982	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—psoriasis	0.00201	0.0095	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00196	0.00925	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00193	0.00913	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KIR2DS1—psoriasis	0.00192	0.00909	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—DDX58—psoriasis	0.00188	0.0089	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—NFKBIA—psoriasis	0.00185	0.00875	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	0.00183	0.00864	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NFKBIA—psoriasis	0.00181	0.00854	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—psoriasis	0.00178	0.00841	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—TYK2—psoriasis	0.00175	0.00829	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—JUN—psoriasis	0.00175	0.00826	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—psoriasis	0.00174	0.00821	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—psoriasis	0.00171	0.00809	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—TYK2—psoriasis	0.00171	0.00806	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—TYK2—psoriasis	0.00171	0.00806	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—TYK2—psoriasis	0.00169	0.00799	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—JUN—psoriasis	0.00169	0.00797	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—NFKB1—psoriasis	0.00168	0.00795	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—psoriasis	0.00167	0.00789	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—TYK2—psoriasis	0.00165	0.00778	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—TYK2—psoriasis	0.00165	0.00778	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—TYK2—psoriasis	0.00165	0.00778	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—psoriasis	0.00162	0.00767	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00159	0.0075	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—JUN—psoriasis	0.00155	0.00734	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	0.00149	0.00706	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—DDX58—psoriasis	0.00149	0.00703	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TYK2—psoriasis	0.00148	0.00699	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	0.00144	0.00683	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NFKBIA—psoriasis	0.00143	0.00675	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—psoriasis	0.00141	0.00665	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—JUN—psoriasis	0.00138	0.00653	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—TYK2—psoriasis	0.00137	0.00646	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—psoriasis	0.00135	0.0064	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—JUN—psoriasis	0.00133	0.0063	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NFKB1—psoriasis	0.00133	0.00628	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL8—psoriasis	0.00132	0.00624	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	0.0013	0.00616	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFIH1—psoriasis	0.0013	0.00612	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—psoriasis	0.00128	0.00606	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERAP1—psoriasis	0.00125	0.00588	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-C—psoriasis	0.00123	0.0058	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—JUN—psoriasis	0.00123	0.0058	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TNFAIP3—psoriasis	0.00121	0.00573	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	0.00121	0.00573	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—JUN—psoriasis	0.0012	0.00566	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	0.00118	0.00558	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TYK2—psoriasis	0.00117	0.00553	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	0.00117	0.00551	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—psoriasis	0.00116	0.00549	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.00115	0.00545	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—DDX58—psoriasis	0.0011	0.00518	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—psoriasis	0.00108	0.00508	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	0.00106	0.00499	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	0.00103	0.00487	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IFIH1—psoriasis	0.00102	0.00484	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-E—psoriasis	0.00102	0.00482	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	0.00102	0.00481	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERAP1—psoriasis	0.000984	0.00465	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-C—psoriasis	0.000971	0.00459	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TNFAIP3—psoriasis	0.000959	0.00453	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	0.000958	0.00453	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—JUN—psoriasis	0.000947	0.00448	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.000938	0.00443	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	0.000922	0.00436	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—psoriasis	0.000919	0.00434	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.000912	0.00431	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	0.000907	0.00429	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HCAR2—psoriasis	0.000886	0.00419	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—DDX58—psoriasis	0.000867	0.0041	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—psoriasis	0.000858	0.00405	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—SOCS1—psoriasis	0.000851	0.00402	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—psoriasis	0.00085	0.00402	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000843	0.00398	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—psoriasis	0.000834	0.00394	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	0.000834	0.00394	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000831	0.00393	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ITGAL—psoriasis	0.000831	0.00393	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—psoriasis	0.000827	0.00391	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000817	0.00386	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-E—psoriasis	0.000806	0.00381	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	0.000805	0.00381	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—psoriasis	0.000805	0.00381	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—psoriasis	0.000805	0.00381	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—REL—psoriasis	0.000777	0.00367	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TAGAP—psoriasis	0.000768	0.00363	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFIH1—psoriasis	0.000754	0.00357	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.000741	0.0035	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	0.000732	0.00346	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-B—psoriasis	0.000726	0.00343	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—psoriasis	0.000724	0.00342	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	0.000717	0.00339	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-C—psoriasis	0.000715	0.00338	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TNFAIP3—psoriasis	0.000706	0.00334	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—SOCS1—psoriasis	0.000673	0.00318	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—psoriasis	0.000669	0.00316	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ITGAL—psoriasis	0.000657	0.0031	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CRP—psoriasis	0.000642	0.00303	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—REL—psoriasis	0.000614	0.0029	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFIH1—psoriasis	0.000596	0.00282	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-E—psoriasis	0.000594	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NFKBIA—psoriasis	0.000585	0.00277	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	0.000579	0.00274	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-B—psoriasis	0.000574	0.00271	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—psoriasis	0.000572	0.0027	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-C—psoriasis	0.000565	0.00267	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TNFAIP3—psoriasis	0.000558	0.00264	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CRP—psoriasis	0.000507	0.0024	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—SOCS1—psoriasis	0.000496	0.00234	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000486	0.0023	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TYK2—psoriasis	0.000479	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HLA-E—psoriasis	0.000469	0.00222	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NFKBIA—psoriasis	0.000463	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL20—psoriasis	0.00046	0.00217	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD8A—psoriasis	0.00044	0.00208	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD4—psoriasis	0.000434	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-B—psoriasis	0.000423	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SOCS1—psoriasis	0.000392	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-A—psoriasis	0.000392	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—JUN—psoriasis	0.000388	0.00183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TYK2—psoriasis	0.000379	0.00179	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CRP—psoriasis	0.000374	0.00177	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NFKB1—psoriasis	0.000374	0.00177	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Hydrocortisone—psoriasis	0.000362	0.000604	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-DRB1—psoriasis	0.000358	0.00169	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Cyclosporine—psoriasis	0.000357	0.000595	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisolone—psoriasis	0.000357	0.000595	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Cyclosporine—psoriasis	0.000356	0.000594	CcSEcCtD
Hydroxychloroquine—Vertigo—Hydrocortisone—psoriasis	0.000356	0.000594	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mycophenolic acid—psoriasis	0.000356	0.000593	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mycophenolic acid—psoriasis	0.000356	0.000593	CcSEcCtD
Hydroxychloroquine—Dizziness—Hydroxyurea—psoriasis	0.000355	0.000592	CcSEcCtD
Hydroxychloroquine—Oedema—Mycophenolate mofetil—psoriasis	0.000355	0.000592	CcSEcCtD
Hydroxychloroquine—Skin disorder—Cyclosporine—psoriasis	0.000354	0.00059	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisolone—psoriasis	0.000352	0.000586	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Methotrexate—psoriasis	0.00035	0.000584	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Hydrocortisone—psoriasis	0.000348	0.000581	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000348	0.000581	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000348	0.00058	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD8A—psoriasis	0.000348	0.00164	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Cyclosporine—psoriasis	0.000347	0.000579	CcSEcCtD
Hydroxychloroquine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000345	0.000575	CcSEcCtD
Hydroxychloroquine—Alopecia—Betamethasone—psoriasis	0.000344	0.000573	CcSEcCtD
Hydroxychloroquine—Alopecia—Dexamethasone—psoriasis	0.000344	0.000573	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ICAM1—psoriasis	0.000344	0.00162	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Hydrocortisone—psoriasis	0.000343	0.000573	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CD4—psoriasis	0.000343	0.00162	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Hydroxyurea—psoriasis	0.000342	0.00057	CcSEcCtD
Hydroxychloroquine—Angioedema—Triamcinolone—psoriasis	0.000341	0.000569	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—NFKBIA—psoriasis	0.000341	0.00161	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Prednisone—psoriasis	0.000341	0.000568	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisone—psoriasis	0.000339	0.000565	CcSEcCtD
Hydroxychloroquine—Rash—Hydroxyurea—psoriasis	0.000339	0.000565	CcSEcCtD
Hydroxychloroquine—Anorexia—Mycophenolate mofetil—psoriasis	0.000338	0.000564	CcSEcCtD
Hydroxychloroquine—Dermatitis—Hydroxyurea—psoriasis	0.000338	0.000564	CcSEcCtD
Hydroxychloroquine—Headache—Hydroxyurea—psoriasis	0.000337	0.000561	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—psoriasis	0.000336	0.00056	CcSEcCtD
Hydroxychloroquine—Vertigo—Triamcinolone—psoriasis	0.000335	0.000559	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000335	0.000559	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-B—psoriasis	0.000334	0.00158	CbGpPWpGaD
Hydroxychloroquine—Oedema—Prednisolone—psoriasis	0.000331	0.000552	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Triamcinolone—psoriasis	0.000328	0.000547	CcSEcCtD
Hydroxychloroquine—Somnolence—Cyclosporine—psoriasis	0.000324	0.00054	CcSEcCtD
Hydroxychloroquine—Oedema—Hydrocortisone—psoriasis	0.000324	0.000539	CcSEcCtD
Hydroxychloroquine—Convulsion—Triamcinolone—psoriasis	0.000323	0.000539	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—psoriasis	0.000323	0.000538	CcSEcCtD
Hydroxychloroquine—Asthenia—Mycophenolic acid—psoriasis	0.000323	0.000538	CcSEcCtD
Hydroxychloroquine—Nausea—Hydroxyurea—psoriasis	0.000319	0.000532	CcSEcCtD
Hydroxychloroquine—Pruritus—Mycophenolic acid—psoriasis	0.000318	0.000531	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Hydrocortisone—psoriasis	0.000317	0.000529	CcSEcCtD
Hydroxychloroquine—Eye disorder—Prednisone—psoriasis	0.000317	0.000528	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Cyclosporine—psoriasis	0.000316	0.000528	CcSEcCtD
Hydroxychloroquine—Somnolence—Mycophenolate mofetil—psoriasis	0.000316	0.000526	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—psoriasis	0.000315	0.000526	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—psoriasis	0.000315	0.000524	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000314	0.000524	CcSEcCtD
Hydroxychloroquine—Skin disorder—Hydrocortisone—psoriasis	0.000314	0.000524	CcSEcCtD
Hydroxychloroquine—Fatigue—Cyclosporine—psoriasis	0.000314	0.000523	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000313	0.000521	CcSEcCtD
Hydroxychloroquine—Pain—Cyclosporine—psoriasis	0.000311	0.000519	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-A—psoriasis	0.00031	0.00146	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Betamethasone—psoriasis	0.000309	0.000516	CcSEcCtD
Hydroxychloroquine—Angioedema—Dexamethasone—psoriasis	0.000309	0.000516	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000309	0.000515	CcSEcCtD
Hydroxychloroquine—Anorexia—Hydrocortisone—psoriasis	0.000308	0.000514	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mycophenolic acid—psoriasis	0.000308	0.000513	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—JUN—psoriasis	0.000307	0.00145	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000307	0.000511	CcSEcCtD
Hydroxychloroquine—Oedema—Triamcinolone—psoriasis	0.000305	0.000508	CcSEcCtD
Hydroxychloroquine—Vertigo—Betamethasone—psoriasis	0.000304	0.000507	CcSEcCtD
Hydroxychloroquine—Vertigo—Dexamethasone—psoriasis	0.000304	0.000507	CcSEcCtD
Hydroxychloroquine—Pain—Mycophenolate mofetil—psoriasis	0.000304	0.000506	CcSEcCtD
Hydroxychloroquine—Alopecia—Prednisone—psoriasis	0.000299	0.000499	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000298	0.000496	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Dexamethasone—psoriasis	0.000298	0.000496	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Betamethasone—psoriasis	0.000298	0.000496	CcSEcCtD
Hydroxychloroquine—Dizziness—Mycophenolic acid—psoriasis	0.000298	0.000496	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—psoriasis	0.000297	0.000495	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CRP—psoriasis	0.000296	0.0014	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NFKB1—psoriasis	0.000295	0.0014	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Prednisone—psoriasis	0.000295	0.000492	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—psoriasis	0.000294	0.000491	CcSEcCtD
Hydroxychloroquine—Convulsion—Dexamethasone—psoriasis	0.000293	0.000489	CcSEcCtD
Hydroxychloroquine—Convulsion—Betamethasone—psoriasis	0.000293	0.000489	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00029	0.000484	CcSEcCtD
Hydroxychloroquine—Urticaria—Cyclosporine—psoriasis	0.000289	0.000482	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Cyclosporine—psoriasis	0.000288	0.00048	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Cyclosporine—psoriasis	0.000288	0.00048	CcSEcCtD
Hydroxychloroquine—Vomiting—Mycophenolic acid—psoriasis	0.000286	0.000477	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methotrexate—psoriasis	0.000285	0.000475	CcSEcCtD
Hydroxychloroquine—Rash—Mycophenolic acid—psoriasis	0.000284	0.000473	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mycophenolic acid—psoriasis	0.000283	0.000473	CcSEcCtD
Hydroxychloroquine—Pain—Prednisolone—psoriasis	0.000283	0.000472	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—psoriasis	0.000283	0.000472	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-DRB1—psoriasis	0.000283	0.00134	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Mycophenolate mofetil—psoriasis	0.000282	0.00047	CcSEcCtD
Hydroxychloroquine—Headache—Mycophenolic acid—psoriasis	0.000282	0.00047	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Hydrocortisone—psoriasis	0.000281	0.000469	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000281	0.000468	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000281	0.000468	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000279	0.000466	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TYK2—psoriasis	0.000279	0.00132	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Hydrocortisone—psoriasis	0.000279	0.000465	CcSEcCtD
Hydroxychloroquine—Vision blurred—Prednisone—psoriasis	0.000278	0.000464	CcSEcCtD
Hydroxychloroquine—Pain—Hydrocortisone—psoriasis	0.000277	0.000461	CcSEcCtD
Hydroxychloroquine—Oedema—Betamethasone—psoriasis	0.000276	0.000461	CcSEcCtD
Hydroxychloroquine—Oedema—Dexamethasone—psoriasis	0.000276	0.000461	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—psoriasis	0.000273	0.000455	CcSEcCtD
Hydroxychloroquine—Anaemia—Prednisone—psoriasis	0.000273	0.000455	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ICAM1—psoriasis	0.000272	0.00128	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Betamethasone—psoriasis	0.000271	0.000452	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Dexamethasone—psoriasis	0.000271	0.000452	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—psoriasis	0.000271	0.000452	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Betamethasone—psoriasis	0.000271	0.000451	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Dexamethasone—psoriasis	0.000271	0.000451	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisone—psoriasis	0.000269	0.000449	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NFKBIA—psoriasis	0.000269	0.00127	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Cyclosporine—psoriasis	0.000268	0.000447	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—psoriasis	0.000268	0.000446	CcSEcCtD
Hydroxychloroquine—Nausea—Mycophenolic acid—psoriasis	0.000267	0.000446	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—psoriasis	0.000265	0.000442	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—psoriasis	0.000265	0.000441	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000265	0.000441	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—psoriasis	0.000264	0.00044	CcSEcCtD
Hydroxychloroquine—Anorexia—Dexamethasone—psoriasis	0.000263	0.000439	CcSEcCtD
Hydroxychloroquine—Anorexia—Betamethasone—psoriasis	0.000263	0.000439	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisolone—psoriasis	0.000263	0.000439	CcSEcCtD
Hydroxychloroquine—Fatigue—Triamcinolone—psoriasis	0.000263	0.000438	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000262	0.000436	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNG—psoriasis	0.000261	0.00124	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Cyclosporine—psoriasis	0.000261	0.000436	CcSEcCtD
Hydroxychloroquine—Pain—Triamcinolone—psoriasis	0.00026	0.000434	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisone—psoriasis	0.000259	0.000432	CcSEcCtD
Hydroxychloroquine—Pruritus—Cyclosporine—psoriasis	0.000258	0.000429	CcSEcCtD
Hydroxychloroquine—Urticaria—Hydrocortisone—psoriasis	0.000257	0.000429	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Hydrocortisone—psoriasis	0.000256	0.000426	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Hydrocortisone—psoriasis	0.000256	0.000426	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—psoriasis	0.000256	0.000426	CcSEcCtD
Hydroxychloroquine—Asthenia—Mycophenolate mofetil—psoriasis	0.000255	0.000425	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SOCS1—psoriasis	0.000253	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—psoriasis	0.000253	0.00119	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Mycophenolate mofetil—psoriasis	0.000251	0.000419	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—psoriasis	0.00025	0.000417	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000249	0.000416	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Cyclosporine—psoriasis	0.000249	0.000415	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—psoriasis	0.000248	0.000414	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—psoriasis	0.000246	0.000411	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisolone—psoriasis	0.000244	0.000407	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000243	0.000405	CcSEcCtD
Hydroxychloroquine—Urticaria—Triamcinolone—psoriasis	0.000242	0.000404	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Triamcinolone—psoriasis	0.000241	0.000402	CcSEcCtD
Hydroxychloroquine—Dizziness—Cyclosporine—psoriasis	0.000241	0.000401	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—psoriasis	0.000241	0.000401	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dexamethasone—psoriasis	0.00024	0.000401	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Betamethasone—psoriasis	0.00024	0.000401	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000239	0.000398	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000239	0.000398	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Hydrocortisone—psoriasis	0.000238	0.000397	CcSEcCtD
Hydroxychloroquine—Fatigue—Betamethasone—psoriasis	0.000238	0.000397	CcSEcCtD
Hydroxychloroquine—Fatigue—Dexamethasone—psoriasis	0.000238	0.000397	CcSEcCtD
Hydroxychloroquine—Pain—Betamethasone—psoriasis	0.000236	0.000394	CcSEcCtD
Hydroxychloroquine—Pain—Dexamethasone—psoriasis	0.000236	0.000394	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Prednisone—psoriasis	0.000236	0.000394	CcSEcCtD
Hydroxychloroquine—Dizziness—Mycophenolate mofetil—psoriasis	0.000235	0.000392	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—psoriasis	0.000234	0.00111	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Prednisone—psoriasis	0.000234	0.00039	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—psoriasis	0.000232	0.000387	CcSEcCtD
Hydroxychloroquine—Asthenia—Hydrocortisone—psoriasis	0.000232	0.000387	CcSEcCtD
Hydroxychloroquine—Vomiting—Cyclosporine—psoriasis	0.000231	0.000386	CcSEcCtD
Hydroxychloroquine—Rash—Cyclosporine—psoriasis	0.00023	0.000383	CcSEcCtD
Hydroxychloroquine—Anorexia—Prednisone—psoriasis	0.000229	0.000383	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cyclosporine—psoriasis	0.000229	0.000382	CcSEcCtD
Hydroxychloroquine—Pruritus—Hydrocortisone—psoriasis	0.000229	0.000382	CcSEcCtD
Hydroxychloroquine—Headache—Cyclosporine—psoriasis	0.000228	0.00038	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—psoriasis	0.000228	0.00038	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—JUN—psoriasis	0.000226	0.00107	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Betamethasone—psoriasis	0.000226	0.000377	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000226	0.000377	CcSEcCtD
Hydroxychloroquine—Vomiting—Mycophenolate mofetil—psoriasis	0.000226	0.000377	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Triamcinolone—psoriasis	0.000224	0.000374	CcSEcCtD
Hydroxychloroquine—Rash—Mycophenolate mofetil—psoriasis	0.000224	0.000373	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000224	0.000373	CcSEcCtD
Hydroxychloroquine—Headache—Mycophenolate mofetil—psoriasis	0.000222	0.000371	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—psoriasis	0.000221	0.000369	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Hydrocortisone—psoriasis	0.000221	0.000369	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TYK2—psoriasis	0.000221	0.00104	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Methotrexate—psoriasis	0.000221	0.000368	CcSEcCtD
Hydroxychloroquine—Urticaria—Dexamethasone—psoriasis	0.00022	0.000366	CcSEcCtD
Hydroxychloroquine—Urticaria—Betamethasone—psoriasis	0.00022	0.000366	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisolone—psoriasis	0.000219	0.000365	CcSEcCtD
Hydroxychloroquine—Asthenia—Triamcinolone—psoriasis	0.000219	0.000364	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Betamethasone—psoriasis	0.000219	0.000364	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Betamethasone—psoriasis	0.000219	0.000364	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dexamethasone—psoriasis	0.000219	0.000364	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dexamethasone—psoriasis	0.000219	0.000364	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—NFKB1—psoriasis	0.000218	0.00103	CbGpPWpGaD
Hydroxychloroquine—Nausea—Cyclosporine—psoriasis	0.000216	0.000361	CcSEcCtD
Hydroxychloroquine—Pruritus—Triamcinolone—psoriasis	0.000216	0.000359	CcSEcCtD
Hydroxychloroquine—Dizziness—Hydrocortisone—psoriasis	0.000214	0.000357	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—psoriasis	0.000214	0.000356	CcSEcCtD
Hydroxychloroquine—Nausea—Mycophenolate mofetil—psoriasis	0.000211	0.000352	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Prednisone—psoriasis	0.000209	0.000349	CcSEcCtD
Hydroxychloroquine—Rash—Prednisolone—psoriasis	0.000209	0.000348	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisolone—psoriasis	0.000209	0.000348	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000208	0.000348	CcSEcCtD
Hydroxychloroquine—Fatigue—Prednisone—psoriasis	0.000208	0.000346	CcSEcCtD
Hydroxychloroquine—Headache—Prednisolone—psoriasis	0.000208	0.000346	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNG—psoriasis	0.000207	0.000977	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Hydrocortisone—psoriasis	0.000206	0.000343	CcSEcCtD
Hydroxychloroquine—Rash—Hydrocortisone—psoriasis	0.000204	0.00034	CcSEcCtD
Hydroxychloroquine—Dermatitis—Hydrocortisone—psoriasis	0.000204	0.00034	CcSEcCtD
Hydroxychloroquine—Headache—Hydrocortisone—psoriasis	0.000203	0.000338	CcSEcCtD
Hydroxychloroquine—Dizziness—Triamcinolone—psoriasis	0.000201	0.000336	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD4—psoriasis	0.0002	0.000943	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Dexamethasone—psoriasis	0.000198	0.000331	CcSEcCtD
Hydroxychloroquine—Asthenia—Betamethasone—psoriasis	0.000198	0.000331	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—psoriasis	0.000197	0.000329	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—psoriasis	0.000197	0.000328	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—psoriasis	0.000197	0.000328	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisolone—psoriasis	0.000197	0.000328	CcSEcCtD
Hydroxychloroquine—Pruritus—Dexamethasone—psoriasis	0.000196	0.000326	CcSEcCtD
Hydroxychloroquine—Pruritus—Betamethasone—psoriasis	0.000196	0.000326	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—STAT3—psoriasis	0.000196	0.000924	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Methotrexate—psoriasis	0.000195	0.000326	CcSEcCtD
Hydroxychloroquine—Vomiting—Triamcinolone—psoriasis	0.000194	0.000323	CcSEcCtD
Hydroxychloroquine—Nausea—Hydrocortisone—psoriasis	0.000192	0.00032	CcSEcCtD
Hydroxychloroquine—Rash—Triamcinolone—psoriasis	0.000192	0.00032	CcSEcCtD
Hydroxychloroquine—Dermatitis—Triamcinolone—psoriasis	0.000192	0.00032	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—psoriasis	0.000192	0.00032	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisone—psoriasis	0.000191	0.000319	CcSEcCtD
Hydroxychloroquine—Headache—Triamcinolone—psoriasis	0.000191	0.000318	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—psoriasis	0.00019	0.000317	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—psoriasis	0.00019	0.000317	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dexamethasone—psoriasis	0.000189	0.000315	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Betamethasone—psoriasis	0.000189	0.000315	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—psoriasis	0.000187	0.000884	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOE—psoriasis	0.000187	0.000884	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—psoriasis	0.000185	0.000876	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Betamethasone—psoriasis	0.000183	0.000305	CcSEcCtD
Hydroxychloroquine—Dizziness—Dexamethasone—psoriasis	0.000183	0.000305	CcSEcCtD
Hydroxychloroquine—Nausea—Triamcinolone—psoriasis	0.000181	0.000302	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—psoriasis	0.000179	0.000298	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—JUN—psoriasis	0.000179	0.000844	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Prednisone—psoriasis	0.000177	0.000296	CcSEcCtD
Hydroxychloroquine—Vomiting—Dexamethasone—psoriasis	0.000176	0.000293	CcSEcCtD
Hydroxychloroquine—Vomiting—Betamethasone—psoriasis	0.000176	0.000293	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—psoriasis	0.000175	0.000292	CcSEcCtD
Hydroxychloroquine—Rash—Dexamethasone—psoriasis	0.000174	0.000291	CcSEcCtD
Hydroxychloroquine—Rash—Betamethasone—psoriasis	0.000174	0.000291	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NFKBIA—psoriasis	0.000174	0.000823	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Betamethasone—psoriasis	0.000174	0.00029	CcSEcCtD
Hydroxychloroquine—Dermatitis—Dexamethasone—psoriasis	0.000174	0.00029	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000174	0.00029	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—psoriasis	0.000173	0.000289	CcSEcCtD
Hydroxychloroquine—Headache—Dexamethasone—psoriasis	0.000173	0.000289	CcSEcCtD
Hydroxychloroquine—Headache—Betamethasone—psoriasis	0.000173	0.000289	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—psoriasis	0.000173	0.000288	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—psoriasis	0.000172	0.000287	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NFKB1—psoriasis	0.000172	0.000813	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Prednisone—psoriasis	0.00017	0.000284	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metabolism—NDUFA5—psoriasis	0.00017	0.000801	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Prednisone—psoriasis	0.000165	0.000275	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—psoriasis	0.000165	0.000274	CcSEcCtD
Hydroxychloroquine—Nausea—Betamethasone—psoriasis	0.000164	0.000274	CcSEcCtD
Hydroxychloroquine—Nausea—Dexamethasone—psoriasis	0.000164	0.000274	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—psoriasis	0.00016	0.000266	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—psoriasis	0.000159	0.000265	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—psoriasis	0.000159	0.000265	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—psoriasis	0.000159	0.000265	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—STAT3—psoriasis	0.000155	0.00073	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Prednisone—psoriasis	0.000153	0.000255	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—psoriasis	0.000152	0.000253	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—psoriasis	0.000152	0.000253	CcSEcCtD
Hydroxychloroquine—Headache—Prednisone—psoriasis	0.000151	0.000251	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methotrexate—psoriasis	0.000148	0.000247	CcSEcCtD
Hydroxychloroquine—Asthenia—Methotrexate—psoriasis	0.000144	0.000241	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2S1—psoriasis	0.000144	0.000681	CbGpPWpGaD
Hydroxychloroquine—Nausea—Prednisone—psoriasis	0.000143	0.000238	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TYK2—psoriasis	0.000143	0.000674	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Methotrexate—psoriasis	0.000142	0.000237	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methotrexate—psoriasis	0.000138	0.00023	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IL6—psoriasis	0.000137	0.000645	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Methotrexate—psoriasis	0.000133	0.000222	CcSEcCtD
Hydroxychloroquine—Vomiting—Methotrexate—psoriasis	0.000128	0.000213	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—psoriasis	0.000127	0.000212	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—psoriasis	0.000127	0.000211	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—psoriasis	0.000126	0.00021	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—psoriasis	0.000124	0.000587	CbGpPWpGaD
Hydroxychloroquine—Nausea—Methotrexate—psoriasis	0.000119	0.000199	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—JUN—psoriasis	0.000116	0.000546	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NFKB1—psoriasis	0.000111	0.000525	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—psoriasis	0.000108	0.00051	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—psoriasis	0.000101	0.000477	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—psoriasis	9.99e-05	0.000472	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—psoriasis	7.63e-05	0.00036	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CARM1—psoriasis	7.04e-05	0.000333	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—psoriasis	6.98e-05	0.00033	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAT—psoriasis	4.33e-05	0.000205	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOE—psoriasis	3.36e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—psoriasis	2.93e-05	0.000138	CbGpPWpGaD
